v3.24.1.1.u2
PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
PREFERRED STOCK AND COMMON SHAREHOLDERS' EQUITY PREFERRED STOCK AND COMMON SHAREHOLDERS’ EQUITY
The Company is authorized to issue up to 265.0 shares of common stock, par value $0.001 per share. The Company is authorized to issue up to 30.0 shares of preferred stock, par value $0.001 per share. There were no preferred shares outstanding as of March 31, 2024 and December 31, 2023.
Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss) are as follows:
Three months ended March 31, 2024
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at December 31, 2023$(206.7)$(7.4)$(1.4)$(215.5)
Current quarter foreign exchange adjustments(27.7)— — (27.7)
Unrealized gain on derivative instrument— — 2.5 2.5
Amounts reclassified from other accumulated income (loss)— — (0.4)(0.4)
Tax effect of adjustments— — (0.5)(0.5)
Balance at March 31, 2024$(234.4)$(7.4)$0.2 $(241.6)
Three months ended March 31, 2023
Foreign Currency Translation AdjustmentsNet Benefit Plan AdjustmentsUnrealized Gain (Loss) on Derivative InstrumentsAccumulated Other Comprehensive Income (Loss)
Balance at December 31, 2022$(266.0)$(8.8)$— $(274.8)
Current quarter foreign exchange adjustments19.1 — — 19.1 
Balance at March 31, 2023$(246.9)$(8.8)$— $(255.7)